In lymphopenic patients a decline of both CD4+ and CD19+ cells was noted, but classical opportunistic infections, as that from Pneumocystis jirovecii, did not occur in our cohort of AT patients, indicating that the quantitative deterioration of these cells does not equate a functional progressive immune deficiency. The gene discussed is CD19; the disease is Immunodeficiency.